-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VVvIp8uc8LlJPHzKlmjrkEAJSnL4Dr6tZqRlukZQLA7RLJ2vGGcy+Rfx4ntE2vr2 wkCr7N7OP8h3Y/cEZHdkmw== 0000950005-09-000171.txt : 20090402 0000950005-09-000171.hdr.sgml : 20090402 20090402165918 ACCESSION NUMBER: 0000950005-09-000171 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20090402 DATE AS OF CHANGE: 20090402 GROUP MEMBERS: ALAIN L. AZAN GROUP MEMBERS: ERIC P. BUATOIS GROUP MEMBERS: JAMES I. HEALY, M.D., PH.D GROUP MEMBERS: MICHAEL F. POWELL GROUP MEMBERS: SOFINNOVA MANAGEMENT V 2005, L.L.C. GROUP MEMBERS: SOFINNOVA MANAGEMENT V, L.L.C. GROUP MEMBERS: SOFINNOVA MANAGEMENT VII, L.L.C GROUP MEMBERS: SOFINNOVA VENTURE AFFILIATES V, L.P GROUP MEMBERS: SOFINNOVA VENTURE PARTNERS V, L.P. GROUP MEMBERS: SOFINNOVA VENTURE PARTNERS VII, L.P. GROUP MEMBERS: SOFINNOVA VENTURE PRINCIPALS V, L.P FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SOFINNOVA VENTURE PARTNERS V LP CENTRAL INDEX KEY: 0001108554 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 140 GEARY STREET STREET 2: 10TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94108 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ANESIVA, INC. CENTRAL INDEX KEY: 0001131517 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770503399 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-79795 FILM NUMBER: 09728432 BUSINESS ADDRESS: STREET 1: 650 GATEWAY BOULEVARD STREET 2: -- CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6506249600 MAIL ADDRESS: STREET 1: 650 GATEWAY BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: CORGENTECH INC DATE OF NAME CHANGE: 20010106 SC 13D/A 1 p20613sc13da.htm SCHEDULE 13D/A #4 Converted by EDGARwiz

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549


SCHEDULE 13D

(RULE 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE § 240.13d-2(a)


(Amendment No. 4)*

ANESIVA, INC.

------------------------------------------------------------------------------------------------------------

(Name of Issuer)

COMMON STOCK

------------------------------------------------------------------------------------------------------------

(Title of Class of Securities)

03460L100

------------------------------------------------------------------------------------------------------------

(CUSIP Number)


Nathalie Auber

Sofinnova Ventures, Inc.

140 Geary Street, 10th Floor
San Francisco, CA 94108
(415) 228-3393


------------------------------------------------------------------------------------------------------------

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)


April 1, 2009

------------------------------------------------------------------------------------------------------------

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box |_|.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.




-----------------------------------

------------------------

CUSIP NO. 03460L100

SCHEDULE 13D

        Page 2 of 9

-----------------------------------

------------------------



This Amendment No. 4 (“Amendment No. 4”) amends and supplements the Schedule 13D as originally filed on December 27, 2005, and as amended on December 21, 2007, January 28, 2009 and March 4, 2009 (as so amended, the “Original Schedule 13D”) to report events in connection with the sale of securities by Anesiva, Inc. (the “Company”), a Delaware corporation, formerly known as Corgentech, Inc., in a private placement transaction on April 1, 2009.


This Amendment No. 4 is being filed on behalf of Sofinnova Venture Partners V, L.P., Sofinnova Affiliates V, L.P., Sofinnova Venture Principals V, L.P., Sofinnova Management V, L.L.C., Sofinnova Management V 2005, L.L.C., Sofinnova Venture Partners VII, L.P., Sofinnova Management VII, L.L.C., Michael F. Powell, Alain L. Azan, James I. Healy, M.D., Ph.D. and Eric P. Buatois.


All terms used, but not defined, in this Amendment No. 4 are as defined in the Original Schedule 13D.  The summary descriptions contained herein of certain agreements and documents are qualified in their entirety by reference to the complete text of such agreements and documents filed as Exhibits hereto or incorporated herein by reference.


Item 4.

Purpose of the Transaction.


Item 4 of the Original Schedule 13D, “Purpose of the Transaction,” is amended by adding the following:


On April 1, 2009, Sofinnova Venture Partners VII, L.P. invested an additional $540,000 pursuant to the terms and conditions of the Agreement and received a Security in the same principal amount.  The Security has the same terms and conditions as the Securities purchased by Sofinnova Venture Partners VII, L.P. on January 20, 2009 and on March 3, 2009.

  

Item 7.

Material to be Filed as Exhibits.


Item 7 of the Original Schedule 13D, “Material to be Filed as Exhibits,” is amended by adding the following:


Exhibit A

Agreement of Joint Filing





-----------------------------------

------------------------

CUSIP NO. 03460L100

SCHEDULE 13D

        Page 3 of 9

-----------------------------------

------------------------




SIGNATURES


After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


Dated:  April 2, 2009


SOFINNOVA VENTURE PARTNERS V, L.P.,

a Delaware Limited Partnership


By:  

Sofinnova Management V, L.L.C.,

a Delaware Limited Liability Company


By:

Sofinnova Management V 2005, L.L.C.,

a Delaware Limited Liability Company


Its:

General Partners


By:

/s/ Nathalie Auber                                   

Nathalie Auber

Attorney-in-Fact




SOFINNOVA VENTURE AFFILIATES V, L.P.,

a Delaware Limited Partnership


By:  

Sofinnova Management V, L.L.C.,

a Delaware Limited Liability Company


Its:

General Partner


By:

/s/ Nathalie Auber                                   

Nathalie Auber

Attorney-in-Fact




-----------------------------------

------------------------

CUSIP NO. 03460L100

SCHEDULE 13D

        Page 4 of 9

-----------------------------------

------------------------




SOFINNOVA VENTURE PRINCIPALS V, L.P.,

a Delaware Limited Partnership


By:  

Sofinnova Management V, L.L.C.,

a Delaware Limited Liability Company


Its:

General Partner


By:

/s/ Nathalie Auber                                   

Nathalie Auber

Attorney-in-Fact


SOFINNOVA MANAGEMENT V, L.L.C.,

a Delaware Limited Liability Company


By:

/s/ Nathalie Auber                                   

Nathalie Auber

Attorney-in-Fact



SOFINNOVA MANAGEMENT V 2005, L.L.C.,

a Delaware Limited Liability Company


By:

/s/ Nathalie Auber                                   

Nathalie Auber

Attorney-in-Fact



SOFINNOVA VENTURE PARTNERS VII, L.P.,

a Delaware Limited Partnership


By:  

Sofinnova Management VII, L.L.C.,

a Delaware Limited Liability Company


Its:

General Partner


By:

/s/ Nathalie Auber                                   

Nathalie Auber

Attorney-in-Fact




-----------------------------------

------------------------

CUSIP NO. 03460L100

SCHEDULE 13D

        Page 5 of 9

-----------------------------------

------------------------




SOFINNOVA MANAGEMENT VII, L.L.C.,

a Delaware Limited Liability Company


By:

/s/ Nathalie Auber                                   

Nathalie Auber

Attorney-in-Fact




JAMES I. HEALY, M.D., PH.D.


By:

/s/ Nathalie Auber                                   

Nathalie Auber

Attorney-in-Fact




MICHAEL F. POWELL


By:

/s/ Nathalie Auber                                   

Nathalie Auber

Attorney-in-Fact




ALAIN L. AZAN


By:

/s/ Nathalie Auber                                   

Nathalie Auber

Attorney-in-Fact




ERIC P. BUATOIS


By:

/s/ Nathalie Auber                                   

Nathalie Auber

Attorney-in-Fact




-----------------------------------

------------------------

CUSIP NO. 03460L100

SCHEDULE 13D

        Page 6 of 9

-----------------------------------

------------------------





EXHIBIT INDEX



Exhibit A

Agreement of Joint Filing







-----------------------------------

------------------------

CUSIP NO. 03460L100

SCHEDULE 13D

        Page 7 of 9

-----------------------------------

------------------------



Exhibit A


AGREEMENT OF JOINT FILING


The undersigned hereby agree that a single Schedule 13D (or any amendment thereto) relating to the common stock of Anesiva, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13D.


Dated:  April 2, 2009



SOFINNOVA VENTURE PARTNERS V, L.P.,

a Delaware Limited Partnership


By:  

Sofinnova Management V, L.L.C.,

a Delaware Limited Liability Company


By:

Sofinnova Management V 2005, L.L.C.,

a Delaware Limited Liability Company


Its:

General Partners


By:

/s/ Nathalie Auber                                   

Nathalie Auber

Attorney-in-Fact




SOFINNOVA VENTURE AFFILIATES V, L.P.,

a Delaware Limited Partnership


By:  

Sofinnova Management V, L.L.C.,

a Delaware Limited Liability Company


Its:

General Partner


By:

/s/ Nathalie Auber                                   

Nathalie Auber

Attorney-in-Fact




-----------------------------------

------------------------

CUSIP NO. 03460L100

SCHEDULE 13D

        Page 8 of 9

-----------------------------------

------------------------




SOFINNOVA VENTURE PRINCIPALS V, L.P.,

a Delaware Limited Partnership


By:  

Sofinnova Management V, L.L.C.,

a Delaware Limited Liability Company


Its:

General Partner


By:

/s/ Nathalie Auber                                   

Nathalie Auber

Attorney-in-Fact



SOFINNOVA MANAGEMENT V, L.L.C.,

a Delaware Limited Liability Company


By:

/s/ Nathalie Auber                                   

Nathalie Auber

Attorney-in-Fact



SOFINNOVA MANAGEMENT V 2005, L.L.C.,

a Delaware Limited Liability Company


By:

/s/ Nathalie Auber                                   

Nathalie Auber

Attorney-in-Fact



SOFINNOVA VENTURE PARTNERS VII, L.P.,

a Delaware Limited Partnership


By:  

Sofinnova Management VII, L.L.C.,

a Delaware Limited Liability Company


Its:

General Partner


By:

/s/ Nathalie Auber                                   

Nathalie Auber

Attorney-in-Fact




-----------------------------------

------------------------

CUSIP NO. 03460L100

SCHEDULE 13D

        Page 9 of 9

-----------------------------------

------------------------




SOFINNOVA MANAGEMENT VII, L.L.C.,

a Delaware Limited Liability Company


By:

/s/ Nathalie Auber                                   

Nathalie Auber

Attorney-in-Fact




JAMES I. HEALY, M.D., PH.D.


By:

/s/ Nathalie Auber                                   

Nathalie Auber

Attorney-in-Fact




MICHAEL F. POWELL


By:

/s/ Nathalie Auber                                   

Nathalie Auber

Attorney-in-Fact




ALAIN L. AZAN


By:

/s/ Nathalie Auber                                   

Nathalie Auber

Attorney-in-Fact




ERIC P. BUATOIS


By:

/s/ Nathalie Auber                                   

Nathalie Auber

Attorney-in-Fact



-----END PRIVACY-ENHANCED MESSAGE-----